Loading…

ClearPoint Neuro announced an agreement to acquire IRRAS Holdings, a San Diego-based medical technology company focused on neurocritical care, including the IRRAflow system for intracranial fluid management. The deal adds over 50 active customers and 10 patent families.
“This is a very strategic merger transaction for ClearPoint Neuro, and we believe this addition is complementary to our vision as we continue to become the world's premier neuro drug delivery partner for the biopharma community”ir.clearpointneuro.com
Summarized from public sources; check the original articles before acting on it.